lutetium has been researched along with Body Weight in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aarts, F; Bleichrodt, RP; Boerman, OC; de Jong, GM; Hendriks, T; Heskamp, S | 1 |
| Matsutomo, N; Nagaki, A; Onoguchi, M | 1 |
| Eriksson, SE; Nilsson, R; Ohlsson, T; Tennvall, J | 1 |
| Czernin, J; Dahlbom, M; Halpern, BS; Quon, A; Ratib, O; Schiepers, C; Silverman, DH; Waldherr, C | 1 |
| Mårtensson, L; Nilsson, R; Ohlsson, T; Senter, P; Sjögren, HO; Strand, SE; Tennvall, J; Wang, Z | 1 |
| Aarts, F; Bleichrodt, RP; Boerman, OC; Hendriks, T; Koppe, MJ; Oyen, WJ | 1 |
| Bonutti, F; Cattaruzzi, E; Cragnolini, E; Floreani, M; Foti, C; Geatti, O; Malisan, MR; Moretti, E; Padovani, R | 1 |
7 other study(ies) available for lutetium and Body Weight
| Article | Year |
|---|---|
Radioimmunotherapy prevents local recurrence of colonic cancer in an experimental model.
Topics: Animals; Antibodies, Monoclonal; Body Weight; Cell Line, Tumor; Colonic Neoplasms; Lutetium; Male; Neoplasm Recurrence, Local; Neoplasm Transplantation; Pentetic Acid; Radioimmunotherapy; Radioisotopes; Rats; Tumor Burden | 2009 |
Patient weight-based acquisition protocols to optimize (18)F-FDG PET/CT image quality.
Topics: Body Weight; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Positron-Emission Tomography; Quality Control; Retrospective Studies; Silicates; Tomography, X-Ray Computed | 2011 |
Repeated radioimmunotherapy with 177Lu-DOTA-BR96 in a syngeneic rat colon carcinoma model.
Topics: Animals; Antibodies, Monoclonal; Blood Platelets; Body Weight; Carcinoma; Cell Line, Tumor; Colonic Neoplasms; Dose-Response Relationship, Radiation; Immunoconjugates; Leukocytes; Lutetium; Male; Radioimmunotherapy; Radioisotopes; Rats; Rats, Inbred BN | 2012 |
Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability.
Topics: Body Weight; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Imaging, Three-Dimensional; Lutetium; Male; Middle Aged; Neoplasms; Posture; Prospective Studies; Radiopharmaceuticals; Silicates; Time Factors; Tomography Scanners, X-Ray Computed; Tomography, Emission-Computed; Tomography, X-Ray Computed | 2004 |
Determining maximal tolerable dose of the monoclonal antibody BR96 labeled with 90Y or 177Lu in rats: establishment of a syngeneic tumor model to evaluate means to improve radioimmunotherapy.
Topics: Animals; Antibodies, Monoclonal; Biotin; Body Weight; Brain; Chelating Agents; Disease Models, Animal; Dose-Response Relationship, Drug; Heterocyclic Compounds, 1-Ring; Leukocytes; Lutetium; Maximum Tolerated Dose; Platelet Count; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rats; Time Factors; Yttrium Radioisotopes | 2005 |
A comparison between radioimmunotherapy and hyperthermic intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis of colonic origin in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Body Weight; Colonic Neoplasms; Combined Modality Therapy; Disease Models, Animal; Hyperthermia, Induced; Infusions, Parenteral; Lutetium; Mitomycin; Neoplasms, Experimental; Peritoneal Neoplasms; Radioimmunotherapy; Rats; Rats, Inbred Strains; Survival Rate; Treatment Outcome | 2007 |
Count-rate analysis from clinical scans in PET with LSO detectors.
Topics: Body Weight; Humans; Image Interpretation, Computer-Assisted; Lutetium; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Silicates; Whole-Body Counting | 2008 |